• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Elimination kinetic of high polar metabolites pool of quinidine from human serum.

作者信息

Camsonne R, Moulin M A, Charbonneau P, Bazin C

出版信息

Int J Clin Pharmacol Ther Toxicol. 1985 Feb;23(2):74-5.

PMID:3988396
Abstract

The elimination half-life of high polar metabolites pool of quinidine (t1/2 beta = 6.1 h) has been determined in a quinidine phenobarbiturate intoxicated patient after the complete elimination of quinidine (its precursor) from blood. It is equivalent to the generally accepted t1/2 beta of quinidine (6.1 +/- 1.8 h) but substantially different from the t1/2 beta "hybrid" of 3-hydroxyquinidine (10.0 h) determined in therapeutic conditions in which 3-hydroxyquinidine coexists with quinidine in blood. With regard to the low serum level of quinidine and strong ECG impairments, it is speculated that high polar metabolites of quinidine taken as a whole could be involved in this life threatening intoxication.

摘要

相似文献

1
Elimination kinetic of high polar metabolites pool of quinidine from human serum.
Int J Clin Pharmacol Ther Toxicol. 1985 Feb;23(2):74-5.
2
Dose-dependent kinetics of quinidine in the perfused rat liver preparation. Kinetics of formation of active metabolites.
Drug Metab Dispos. 1982 Nov-Dec;10(6):568-72.
3
[Elimination half-life of 3-hydroxyquinidine in man].[人血浆中3-羟基奎尼丁的消除半衰期]
Therapie. 1983 Jan-Feb;38(1):115-6.
4
Specific determination of quinidine and (3S)-3-hydroxyquinidine in human serum by high-pressure liquid chromatography.采用高压液相色谱法特异性测定人血清中的奎尼丁和(3S)-3-羟基奎尼丁。
J Lab Clin Med. 1977 Nov;90(5):816-22.
5
Fetal supraventricular tachycardia treated with high-dose quinidine: toxicity associated with marked elevation of the metabolite, 3(S)-3-hydroxyquinidine.
Obstet Gynecol. 1987 Sep;70(3 Pt 2):445-9.
6
Disposition kinetics of dihydroquinidine following quinidine administration.
Res Commun Chem Pathol Pharmacol. 1976 Jun;14(2):215-25.
7
Kinetics and electrocardiographic changes after oral 3-OH-quinidine in healthy subjects.健康受试者口服3-羟基奎尼丁后的动力学及心电图变化
Clin Pharmacol Ther. 1985 May;37(5):575-81. doi: 10.1038/clpt.1985.90.
8
Kinetics and dynamics of quinidine-N-oxide in healthy subjects.
Clin Pharmacol Ther. 1987 Sep;42(3):341-5. doi: 10.1038/clpt.1987.158.
9
Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state.
Am Heart J. 1987 Feb;113(2 Pt 1):302-6. doi: 10.1016/0002-8703(87)90269-9.
10
Lack of effect of smoking on the metabolism and pharmacokinetics of quinidine in patients.吸烟对患者奎尼丁代谢及药代动力学无影响。
Br J Clin Pharmacol. 1987 Mar;23(3):351-4. doi: 10.1111/j.1365-2125.1987.tb03057.x.